These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25042469)
1. Stereoselective reduction of C-20 ketone of vitamin D CD-ring and a new synthetic approach to maxacalcitol. Zhao GD; Liu ZP Steroids; 2014 Oct; 88():72-6. PubMed ID: 25042469 [TBL] [Abstract][Full Text] [Related]
2. A new approach to 19-nor-A-ring phosphine oxide for the convergent synthesis of 19-nor-calcitriol. Sigüeiro R; Otero R; González-Berdullas P; Loureiro J; Mouriño A; Maestro MA J Steroid Biochem Mol Biol; 2017 Oct; 173():86-88. PubMed ID: 27592138 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel analogues of 1alpha,25-dihydroxyvitamin D(3) with side chains at C-18. Momán E; Nicoletti D; Mouriño A J Org Chem; 2004 Jul; 69(14):4615-25. PubMed ID: 15230583 [TBL] [Abstract][Full Text] [Related]
5. A-Ring Synthons of 19-Nor Type Vitamin D Derivatives. Akagi Y; Yasui K; Nagasawa K J Steroid Biochem Mol Biol; 2017 Oct; 173():64-68. PubMed ID: 27436062 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects. Chen B; Kawai M; Wu-Wong JR Bioorg Med Chem Lett; 2013 Nov; 23(21):5949-52. PubMed ID: 24035340 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1α,25-dihydroxyvitamin D3 analogues with α-hydroxyalkyl substituents at C12. Carballa DM; Zacconi F; Kulesza U; Mouriño A; Torneiro M J Steroid Biochem Mol Biol; 2013 Jul; 136():34-8. PubMed ID: 23098691 [TBL] [Abstract][Full Text] [Related]
8. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis. Glebocka A; Sicinski RR; DeLuca HF J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741 [TBL] [Abstract][Full Text] [Related]